Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis

Biggioggero, 2010, The geoepidemiology of the antiphospholipid antibody syndrome, Autoimmun Rev, 9, 299, 10.1016/j.autrev.2009.11.013 D'Cruz, 2006, Antiphospholipid (Hughes) syndrome: an overview, 9 Viall, 2015, Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature, Autoimmun Rev, 14, 446, 10.1016/j.autrev.2015.01.008 Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Islam, 2016, ‘Non-criteria’ neurologic manifestations of antiphospholipid syndrome: a hidden kingdom to be discovered, CNS Neurol Disord Drug Targets, 15, 1253, 10.2174/1871527315666160920122750 Merikangas, 2013, Contributions of epidemiology to our understanding of migraine, Headache, 53, 230, 10.1111/head.12038 Jensen, 2008, Epidemiology and comorbidity of headache, Lancet Neurol, 7, 354, 10.1016/S1474-4422(08)70062-0 Vos, 2013, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2163, 10.1016/S0140-6736(12)61729-2 Linde, 2012, The cost of headache disorders in Europe: the Eurolight project, Eur J Neurol, 19, 703, 10.1111/j.1468-1331.2011.03612.x Ferrari, 2015, Migraine pathophysiology: lessons from mouse models and human genetics, Lancet Neurol, 14, 65, 10.1016/S1474-4422(14)70220-0 Arumugam, 2016, Reduction of CD4+ CD25+ regulatory T-cells in migraine: is migraine an autoimmune disorder?, J Neuroimmunol, 290, 54, 10.1016/j.jneuroim.2015.11.015 Kivity, 2010, Can we explain the higher prevalence of autoimmune disease in women?, Expert Rev Clin Immunol, 6, 691, 10.1586/eci.10.60 Lipton, 2001, Prevalence and burden of migraine in the United States: data from the American Migraine Study II, Headache, 41, 646, 10.1046/j.1526-4610.2001.041007646.x Cseh, 2013, Lymphocyte subsets in pediatric migraine, Neurol Sci, 34, 1151, 10.1007/s10072-012-1218-3 Yücel, 2016, Serum levels of endocan, claudin-5 and cytokines in migraine, Eur Rev Med Pharmacol Sci, 20, 930 Tassorelli, 2007, A role for brain cyclooxygenase-2 and prostaglandin-E 2 in migraine: effects of nitroglycerin, Int Rev Neurobiol, 82, 373, 10.1016/S0074-7742(07)82020-4 Martin, 2011, Allergy and immunotherapy: are they related to migraine headache?, Headache, 51, 8, 10.1111/j.1526-4610.2010.01792.x Cavestro, 2011, Migraineurs show a high prevalence of antiphospholipid antibodies, J Thromb Haemost, 9, 1350, 10.1111/j.1538-7836.2011.04348.x Nyandaiti, 2009, Antiphospholipids antibodies and migraine, Sahel Med J, 12, 42 Avcin, 2004, Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine, Cephalalgia, 24, 831, 10.1111/j.1468-2982.2004.00752.x Verrotti, 2000, Lack of association between antiphospholipid antibodies and migraine in children, Int J Clin Lab Res, 30, 109, 10.1007/s005990070023 Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting, JAMA, 283, 2008, 10.1001/jama.283.15.2008 Bashashati, 2014, Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis, Neurogastroenterol Motil, 26, 1036, 10.1111/nmo.12358 Wu, 2016, Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis, Autoimmun Rev, 15, 22, 10.1016/j.autrev.2015.10.002 Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package, J Stat Softw, 36, 1, 10.18637/jss.v036.i03 Iñiguez, 1991, Antiphospholipid antibodies in migraine, Headache, 31, 666, 10.1111/j.1526-4610.1991.hed3110666.x Intiso, 2002, Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients, Neurol Sci, 22, 455, 10.1007/s100720200005 Pilarska, 2005, Antiphospholipid antibodies in children with migraine, Neurol Neurochir Pol, 40, 291 Rajan, 2014, Prothrombotic states in migraine, Clin Appl Thromb Hemost, 20, 851, 10.1177/1076029613486538 Robbins, 1991, Migraine and anticardiolipin antibodies-case reports of 13 patients, and the prevalence of antiphospholipid antibodies in migraineurs, Headache, 31, 537, 10.1111/j.1526-4610.1991.hed3108537.x Straube, 1998, Antinukleäre-und Anticardiolipinantikörper bei primären Kopfschmerzsyndromen, Schmerz, 12, 342, 10.1007/s004820050163 Meiping, 1996, Anticardiolipin antibodies and migraine, Chin J Neuroimmunol Neurol, 3, 206 Mikamo, 1991, Lupus anticoagulant and Thrombomodulin in tension-type headache and migraine, Cephalalgia, 11, 133, 10.1177/0333102491011S1172 Burcin, 2007, Prevalence of anticardiolipin antibodies, lupus anticoagulant, and antibeta 2-glycoprotein I antibodies in migraine with aura, J Neurol, 254, 176 Bruno, 2007, An overview on immune system and migraine, Eur Rev Med Pharmacol Sci, 11, 245 Heesen, 1993, Immunological abnormalities in migraine and cluster headache-epiphenomenon or pathogenetic factors?, Schmerz, 7, 8, 10.1007/BF02527632 Kemper, 2001, Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999, Cephalalgia, 21, 549, 10.1046/j.1468-2982.2001.00196.x Munno, 1998, Cytokines and migraine: increase of IL-5 and IL-4 plasma levels, Headache, 38, 465, 10.1046/j.1526-4610.1998.3806465.x Empl, 1999, T-cell subsets and expression of integrins in peripheral blood of patients with migraine, Cephalalgia, 19, 713, 10.1046/j.1468-2982.1999.019008713.x Leone, 1994, Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache, Cephalalgia, 14, 139, 10.1046/j.1468-2982.1994.1402139.x Kang, 1997, Alpha beta T-helper cell and CD40 ligand dependency in the development of anticardiolipin antibody, Arthritis Rheum, 40, 1701 Arai, 2001, Autoreactive CD4+ T-cell clones to β2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site, Blood, 98, 1889, 10.1182/blood.V98.6.1889 Kuwana, 2003, Autoreactive CD4+ T cells to β2-glycoprotein I in patients with antiphospholipid syndrome, Autoimmun Rev, 2, 192, 10.1016/S1568-9972(03)00007-7 Salem, 2015, β2-glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies, J Biol Chem, 290, 5543, 10.1074/jbc.M114.619817 Visvanathan, 1999, Cellular immunity to β2-glycoprotein-1 in patients with the antiphospholipid syndrome, J Immunol, 162, 6919, 10.4049/jimmunol.162.11.6919 Dal Ben, 2013, Decreased levels of circulating CD4+ CD25+ Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome, J Clin Immunol, 33, 876, 10.1007/s10875-012-9857-y Soroka, 2014, Regulatory T cells in peripheral blood of patients with antiphospholipid syndrome, Ann Rheum Dis, 73, 357, 10.1136/annrheumdis-2014-eular.4485 Dal Ben, 2014, Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4+ CD25+ Foxp3+ Treg and CD3-CD19+ B cells, Rev Bras Reumatol, 54, 241 Fidan, 2006, The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine, J Neuroimmunol, 171, 184, 10.1016/j.jneuroim.2005.10.005 Zencirci, 2006, IL-1, IL-10 and TNF alpha levels during and outside attacks in migraine patients, Eur J Pain, 10, 103, 10.1016/S1090-3801(06)60388-1 Perini, 2005, Plasma cytokine levels in migraineurs and controls, Headache, 45, 926, 10.1111/j.1526-4610.2005.05135.x Franceschini, 2013, TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine, PLoS One, 8, 1, 10.1371/journal.pone.0052394 Durham, 2006, Calcitonin gene-related peptide (CGRP) and migraine, Headache, 46, 3, 10.1111/j.1526-4610.2006.00483.x Swadzba, 2011, Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state, Rheumatol Int, 31, 307, 10.1007/s00296-009-1314-8 Döring, 2010, Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8, Immunobiology, 215, 230, 10.1016/j.imbio.2009.03.002 Berman, 2005, TNF-α is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss, J Immunol, 174, 485, 10.4049/jimmunol.174.1.485 Chighizola, 2016, The hidden world of anti-phospholipid antibodies and female infertility: a literature appraisal, Autoimmun Rev, 15, 493, 10.1016/j.autrev.2016.01.018 Dreier, 2005, Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II, Neurology, 64, 2145, 10.1212/01.WNL.0000176298.63840.99 Cha, 2007, Adult-onset hemiplegic migraine with cortical enhancement and oedema, Cephalalgia, 27, 1166, 10.1111/j.1468-2982.2007.01369.x Gris, 2015, Neuropsychiatric presentations of antiphospholipid antibodies, Thromb Res, 135, S56, 10.1016/S0049-3848(15)50445-3 Katzav, 2014, IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome, J Autoimmun, 55, 86, 10.1016/j.jaut.2014.07.006 Katzav, 2010, The pathogenesis of neural injury in animal models of the antiphospholipid syndrome, Clin Rev Allergy Immunol, 38, 196, 10.1007/s12016-009-8154-x Martinez-Cordero, 1997, Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus, J Investig Allergol Clin Immunol, 7, 596 Gezer, 2003, Antiphospholipid syndrome, Dis Mon, 49, 696, 10.1016/j.disamonth.2003.10.001 Avčin, 2007, Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome, Lupus, 16, 627, 10.1177/0961203307079036